performance of the Company three-month for the Quarter 1/2020 ended 31 March 2020 are as follows: change Q1/2020 Q1/2019 increase (decrease) Sales 224.5 213.9 5.0% Other income 1.9 10.8 -82.3% Cost of sales
second quarter ended June 30, 2020 which the details are as follows: Unit: million Baht For 3-month period (Apr-Jun) 2020 2019 Change % Increase (Decrease) Revenue from sale of goods 128.52 164.02 (35.50
months ended 30th June 2019 Change THB million % THB million % THB million % Sales of electricity 175.94 100.00 85.70 100.00 90.25 105.31 Cost of goods sold (77.17) -43.86 (36.95) -43.12 (40.22) 108.84
10.73% 30 September 2020 31 December 2019 Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin
and its subsidiary for the third quarter ended September 30, 2019 which the details are as follows: Unit: million Baht For 3-month period (July-Sep) 2019 2018 Change % Increase (Decrease) Revenue from
Table 1: Overall Financial Performance Unit: million baht Jan-Sep 2018 % Jan-Sep 2019 % Change % YoY Revenue 380.50 100.0% 440.78 100.0% 60.28 15.8% Cost 217.33 57.1% 238.03 54.0% 20.70 9.5% Gross Profit
difference in the procedures to the extent that it will not materially change the work system and personnel provided in the application; (2) the rules and regulations of the derivatives exchange necessary for
, increased by Bt26.9 million or 22.1%(y-o-y). Such the increment were raised from increasing in the personnel expenses, the consulting and legal fee, the real estate taxes and the depreciation and amortization
amounted to THB 919.43 million, an increase of THB 608.65 million (+195.84%) compared to the end of 2023. This increase was due to the period's profits and the capital raised through the IPO earlier this